Advanced Treatment for IBD: New Targets, New Approaches

Use this downloadable slideset to improve your competence with emerging IBD therapies in clinical practice.
Gary Lichtenstein Headshot
Gary R. Lichtenstein, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 525 KB
Released: September 27, 2018

Acknowledgements

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
Celgene Corporation
Shire

Related Content

Expert commentary from Raymond K. Cross, MD, MS, on management of moderate to severe ulcerative colitis, as reported to Clinical Care Options (CCO)

Raymond K. Cross, MD, MS Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Released: December 14, 2020 Expired: December 13, 2021

CCO slides: current best practice for choosing among biologics and other JAK inhibitors for patients with moderate to severe ulcerative colitis

Released: November 13, 2020

Expert video from Clinical Care Options (CCO) on optimal management of inflammatory bowel disease (IBD), including ulcerative colitis, Crohn disease

Uma Mahadevan, MD William Sandborn, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Released: November 13, 2020 Expired: November 12, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue